Fujifilm Irvine Scientific Launches BalanCD HEK293 Viral Feed

Designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Fujifilm Irvine Scientific Inc., a provider of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has launched its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines. Numerous gene therapies have received FDA approval and as more viral vector-based vaccines and gene thera...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters